Indaptus Therapeutics earnings were -$18.9M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest INDP earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$2.5M, down 68.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, INDP reported annual earnings of -$20.8M, with 38.8% growth. The next INDP earnings date is Aug 12, 2026.
Indaptus Therapeutics Earnings Reports & History FAQ
What were Indaptus Therapeutics's earnings last quarter?
Indaptus Therapeutics (NASDAQ: INDP) reported Q1 2026 earnings per share (EPS) of -$0.23, up 97.48% year over year. Total INDP earnings for the quarter were -$2.54 million. In the same quarter last year, Indaptus Therapeutics's earnings per share (EPS) was -$9.11.
The next INDP earnings date is Invalid Date. Add INDP to your watchlist to be reminded of Indaptus Therapeutics's next earnings date.
What was INDP's earnings growth in the past year?
As of Indaptus Therapeutics's earnings date in Q2 2026, Indaptus Therapeutics's earnings has grown year over year. INDP earnings in the past year totalled -$18.86 million.
Is Indaptus Therapeutics profitable or losing money?
As of the last Indaptus Therapeutics earnings report, Indaptus Therapeutics is currently losing money. Indaptus Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$18.86 million, a 19.75% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.